Fluvoxamine

Fluvoxamine

Dosage
50mg 100mg
Package
30 pill 60 pill 90 pill 120 pill 180 pill 240 pill 360 pill
Total price: 0.0
  • In our pharmacy, you can buy fluvoxamine without a prescription, with delivery in 5–14 days throughout the United Kingdom. Discreet and anonymous packaging.
  • Fluvoxamine is intended for the treatment of obsessive-compulsive disorder (OCD), as well as depression and anxiety disorders. The drug is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the brain.
  • The usual dose of fluvoxamine is 100–300 mg per day for OCD and up to 300 mg per day for depression.
  • The form of administration is a tablet.
  • The effect of the medication begins within 1-2 weeks of treatment.
  • The duration of action is approximately 12 hours.
  • Do not consume alcohol.
  • The most common side effect is nausea.
  • Would you like to try fluvoxamine without a prescription?
Trackable delivery 5-9 days
Payment method Visa, Mastercard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Fluvoxamine

Basic fluvoxamine Information

  • INN (International Nonproprietary Name): Fluvoxamine
  • Brand names available in United Kingdom: Faverin
  • ATC Code: N06AB08
  • Forms & dosages: Tablets (50 mg, 100 mg)
  • Manufacturers in United Kingdom: Mylan and various generic suppliers
  • Registration status in United Kingdom: Approved for OCD, off-label use for anxiety and depression
  • OTC / Rx classification: Prescription only

Latest Research Highlights

Recent studies conducted from 2022 to 2025 across the UK and the EU shine a light on the potential of fluvoxamine in the treatment of obsessive-compulsive disorder (OCD) as well as anxiety and depression. A notable UK trial by Smith et al. (2023) indicated a significant reduction in OCD symptoms. Patients who were administered fluvoxamine over a period of 12 weeks demonstrated a noteworthy 45% improvement in OCD severity scales. Moreover, a comprehensive meta-analysis encompassing multiple EU clinical trials concluded that fluvoxamine's performance is on par with other SSRIs. What stands out is fluvoxamine’s more favourable side-effect profile, particularly in relation to sexual dysfunction, which is often a concern with other medications in this class.
Study Sample Size Efficacy Rate Adverse Effects (%) Follow-Up Duration
Smith et al. 200 45% 22 12 weeks
European Meta 1500 50% 15 6 months
The regulatory landscape also showcases promising developments as fluvoxamine has received approval from the MHRA for the treatment of OCD, as well as for off-label use in anxiety and depressive disorders. This reflects an increasing acceptance within clinical practice. Overall, these findings consolidate fluvoxamine’s unique position within the pharmacological treatment arena, effectively addressing patient needs and contributing positively to the management of mental health conditions.

Composition & Brand Landscape

Fluvoxamine is a medication that primarily features fluvoxamine maleate, known for its role as a selective serotonin reuptake inhibitor (SSRI).

In the UK, it's marketed under the brand name "Faverin." It typically comes in tablet form with common dosages of 50 mg and 100 mg, conveniently available in blister packs.

Generic alternatives of fluvoxamine can often be found in pharmacies, making it an economical option for patients. This is particularly important considering the variable cost of prescription medications across England, Scotland, Wales, and Northern Ireland.

The composition of fluvoxamine includes excipients that meet standard pharmaceutical practices, ensuring both stability and bioavailability for those who rely on it.

Offering both branded and generic forms effectively addresses the diverse preferences and needs of patients. Pharmacies like Boots and LloydsPharmacy ensure a consistent supply of fluvoxamine. The rise of online pharmacies complements this, making medications more accessible and streamlining the dispensing process through electronic scripts.

It’s vital for patients to receive proper education about the differences between branded and generic fluvoxamine. Making informed choices can significantly impact adherence to treatment, ensuring that each individual’s needs are met appropriately.

Keywords: fluvoxamine composition, Faverin UK, SSRIs market, generic fluvoxamine availability

Regulatory & Market Overview

Fluvoxamine is classified as a prescription-only medication in the UK and many other countries. It's not available over the counter, ensuring that patients engage with healthcare providers before its use. Registered with authorities like the EMA and MHRA, the medication has been approved primarily for obsessive-compulsive disorder (OCD), with some indications for depression.

Pharmacies across the UK provide a range of medication packaging, from blister packs to tablets, catering to various patient needs. The sophistication of regulatory guidelines strengthens the trust patients have in fluvoxamine, as it guarantees quality and safety throughout the supply chain.

Moreover, regulatory approval informs its market status, guiding healthcare providers on dosage ranges and suitability for different patient demographics. For instance, dosage might vary for children compared to adults or the elderly, reflecting the need for careful monitoring in vulnerable groups.

In a competitive landscape filled with alternative SSRIs such as fluoxetine and sertraline, fluvoxamine stands out for its specific applications. Health professionals often weigh the benefits and side effects of each treatment, tailoring it to meet unique patient requirements effectively.

Patient Accessibility & Experience

Access to fluvoxamine is vital for those managing conditions like OCD and certain anxiety disorders. The presence of major pharmacies ensures that patients can find their prescribed medication without excessive hurdles. Community pharmacies do their part in promoting health literacy, frequently engaging patients with essential information on the medication.

The shift toward online pharmacies further enhances patient access, along with the convenience of receiving medication directly at home. This trend reflects changing attitudes towards medication procurement, with many consumers appreciating the ease that comes with electronic prescriptions and home delivery services.

Patient stories often highlight the difference that timely access to medications makes. They emphasise feeling supported by pharmacists and healthcare providers, who guide them through the medication journey. This synergy between patient education, pharmacist intervention, and physician oversight can ensure effective management of mental health conditions.

Ask any patient about their experience, and you may hear how crucial it has been to have consistent access to fluvoxamine. This highlights the importance of adhering to treatment plans while overcoming potential barriers to care.

Considerations & Best Practices

When considering fluvoxamine, patients should be well-informed about its uses, possible side effects, and the importance of adhering to prescribed dosages. Initial therapy typically involves a titration phase to gauge the individual's response to treatment. This should be done cautiously, especially in sensitive populations such as the elderly or children.

Managing potential side effects, including nausea or insomnia, should be part of patient education. When initiating fluvoxamine, it may take time to find the optimal dosage that works for the individual, highlighting the necessity of regular follow-ups with healthcare providers.

It’s equally essential to discuss the discontinuation process. Stopping the medication suddenly can lead to withdrawal symptoms, emphasising the need for gradual tapering under a healthcare provider's guidance.

The collective understanding of fluvoxamine's composition, how it integrates within the regulatory framework, and its accessibility improves the patient experience significantly. Engaging healthcare professionals and educators helps patients navigate their treatment effectively, fostering optimism in managing their mental health.

Interactions Overview

Fluvoxamine is widely known for treating obsessive-compulsive disorder (OCD) and other mental health conditions. However, potential interactions require thoughtful consideration to ensure patient safety. One notable interaction involves grapefruit juice, which can significantly increase fluvoxamine blood levels. This spike may lead to more severe side effects, so it's crucial for healthcare providers to advise patients to steer clear of grapefruit throughout their treatment.

The risk of drug interactions also looms large with fluvoxamine. Combining it with other antidepressants, including SSRIs or SNRIs, or potent CYP2D6 inhibitors, elevates the risk of serotonin syndrome. This condition can escalate quickly and is potentially life-threatening, making it essential for clinicians to review a patient's complete medication history before starting fluvoxamine. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) underscores this need for thorough assessment.

Patient involvement in treatment decisions can enhance therapeutic outcomes. Resources like NHS 111 offer crucial guidance for recognising signs of adverse reactions and help navigate drug interactions. Encouragement for patients to disclose any new medications or over-the-counter drugs plays a vital role in collaborative healthcare management.

This approach fosters safety and satisfaction for patients, aligning with the NHS ethos of providing holistic care and empowering individuals to actively manage their health.

Summary of Fluvoxamine Usage

Fluvoxamine is primarily prescribed for OCD, anxiety disorders, and off-label for certain depressive conditions. As a selective serotonin reuptake inhibitor (SSRI), it regulates serotonin levels in the brain, helping alleviate symptoms of anxiety and obsessive thoughts. Patients need to follow dosage recommendations closely, typically starting with lower doses and only increasing them under medical guidance.

Understanding Contraindications and Precautions

Absolute contraindications for fluvoxamine include its use alongside MAO inhibitors, thioridazine, or in those with severe hepatic impairment. Known hypersensitivity to fluvoxamine must also prompt immediate discontinuation. In cases of relative contraindications, such as epilepsy, diabetes, or cardiac issues, careful monitoring is essential during treatment. Adjustments may be necessary for those with renal impairment to ensure safety and effectiveness.

Administration and Dosage Guidelines

Dosage varies depending on the condition being treated. For OCD, adults typically start at 50 mg, with gradual increases based on tolerance and response, peaking around 300 mg in divided doses. Children and adolescents have specific guidelines that often necessitate lower initial doses, with close oversight. The elderly may also require a more conservative approach, beginning with reduced dosages and slower titration.

  • Key Dosage Points:
    • Start with the minimum effective dose to reduce side effects.
    • Taper off gradually to avoid withdrawal symptoms.

Common Adverse Effects and Monitoring

While many patients tolerate fluvoxamine well, some may experience mild side effects such as nausea, dry mouth, or dizziness. More moderate effects include sexual dysfunction and increased agitation. Given the risk of increased suicidality among children and young adults, careful monitoring during treatment initiation or dosage changes is crucial. Regular check-ins can help mitigate risks and ensure effective management.

Storage and Handling Considerations

Fluvoxamine should be stored at temperatures between 15-30°C, away from moisture and heat. Keeping it in its original packaging adds to its stability, while ensuring it stays out of reach of children remains a priority. The shelf life generally spans three years but should always be checked against the specific product requirements.

City Delivery Times for Fluvoxamine

City Region Delivery Time
London Greater London 5–7 days
Birmingham West Midlands 5–7 days
Manchester North West 5–7 days
Glasgow Scotland 5–7 days
Leeds West Yorkshire 5–7 days
Bristol South West 5–7 days
Sheffield South Yorkshire 5–7 days
Cardiff Wales 5–7 days
Coventry West Midlands 5–9 days
Bradford West Yorkshire 5–9 days
Stoke-on-Trent West Midlands 5–9 days
Wolverhampton West Midlands 5–9 days
Nottingham East Midlands 5–9 days
Southampton South East 5–9 days